Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of oral tolvaptan in adults with autosomal dominant polycystic kidney disease (ADPKD)
jRCT2080220393Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- May 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of tolvaptan in autosomal dominant polycystic kidney disease (ADPKD) (4 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Started May 2007; status: completed.
02
Drugs
tolvaptan
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on jRCT2080220393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220393.